slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
200,3 EGP | 0,00% | 0,00% | -8,00% |
Vakgebied
Verkoop per activiteit
EGP in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Bio-production
43,0
%
| 1 106 | 36,8 % | 1 555 | 43,0 % | +40,61% |
Other Services
33,7
%
| 1 343 | 44,7 % | 1 220 | 33,7 % | -9,15% |
Medicine Production
21,6
%
| 499 | 16,6 % | 783 | 21,6 % | +56,91% |
Commercial
1,7
%
| 58 | 1,9 % | 63 | 1,7 % | +8,63% |
Verkoop per regio
EGP in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Egypt
64,0
%
| 2 122 | 70,6 % | 2 318 | 64,0 % | +9,22% |
International
36,0
%
| 883 | 29,4 % | 1 303 | 36,0 % | +47,50% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Executive Officer | - | - | |
Rafiq Raymond
DFI | Director of Finance/CFO | - | - |
Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 293 440 | 3 355 812 ( 27,30 %) | 0 | 27,30 % |
Bedrijfsgegevens
Minapharm Pharmaceuticals
2T Takseem Asmaa Fahmy Street Asmaa Fahmy
11757, Cairo
+202 2414 3170
http://www.minapharm.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,00% | 47,29 mln. | |
+21,26% | 44,4 mld. | |
+24,60% | 23,03 mld. | |
+17,11% | 15,14 mld. | |
+12,99% | 13,12 mld. | |
+44,64% | 11,85 mld. | |
-8,33% | 6,99 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,22% | 5,52 mld. |
- Beurs
- Aandelen
- Koers MIPH
- Onderneming MINAPHARM Pharmaceuticals